Topics

"Recombinant Virus Vectors Treatment Glycogen Storage Disease Type∨derfield=date∨derval=DESC" News Stories

02:31 EDT 19th July 2019 | BioPortfolio

Here are the most relevant search results for "Recombinant Virus Vectors Treatment Glycogen Storage Disease Type∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.

More Information about Recombinant Virus Vectors Treatment Glycogen Storage Disease Type∨derfield=date∨derval=DESC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Recombinant Virus Vectors Treatment Glycogen Storage Disease Type∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list Recombinant Virus Vectors Treatment Glycogen Storage Disease Type∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of Recombinant Virus Vectors Treatment Glycogen Storage Disease Type∨derfield=date∨derval=DESC Companies for you to search.

Showing "Recombinant Virus Vectors Treatment Glycogen Storage Disease Type" News Articles 1–25 of 32,000+

Friday 19th July 2019

Pharmacological targeting of the unfolded protein response for disease intervention


Thursday 18th July 2019

Opinion: Instead of blindly reducing list prices for all drugs, we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. https://buff.ly/32L5J

Opinion: Instead of blindly reducing list prices for all drugs, we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. https://buff.ly/32L5JPY 

Malaysian Mountain Climbing Icon Ravi Everest Joins 9th Annual Expedition Mt. Kinabalu to Raise Awareness for Duchenne Muscular Dystrophy

Organizers highlight ongoing Duchenne research at Kuala Lumpur Hospital and University Malaya Medical Centre NEWPORT BEACH, Calif. (PRWEB) July 18, 2019 World renowned two-time Everest summiter Ravichandran Tharumalingam, who is also known as “Ravi Everest,” will be joining forces with California-based charity Coalition Duchenne for its 9th Annual Expedition Mt. Kinabalu in Sabah, Malaysia, t...


[Articles] Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys

Hypertension awareness, treatment, and control have improved substantially in high-income countries since the 1980s and 1990s. However, control rates have plateaued in the past decade, at levels lower than those in high-quality hypertension programmes. There is substantial variation across countries in the rates of hypertension awareness, treatment, and control.

[Articles] The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults

Our study provides important evidence for the design and targeting of health policies and service interventions for hypertension in LMICs. We show at what steps and for whom there are gaps in the hypertension care process in each of the 44 countries in our study. We also identified countries in each world region that perform better than expected from their economic development, which can direct po...

[Comment] Blood pressure control: a challenge to global health systems

Raised blood pressure is the most important risk factor in the global burden of disease.1 Although there is robust evidence to show that lowering blood pressure can substantially reduce cardiovascular morbidity and mortality,2 the global burden of hypertension is increasing.3,4 To achieve a reduction in the burden of disease related to hypertension, health systems must ensure that high blood press...

Bio-Rad Laboratories ddPCR Microsatellite Instability (MSI) Assay

Bio-Rad’s ddPCR Microsatellite Instability (MSI) Assay can be completed in one day on a ddPCR-based platform to quantify the level of MSI present in colorectal tumours. Using either a blood or FFPE sample, the RUO assay quantitatively identifies mutations in five loci that lead to identification of MSI status. Colorectal tumours that test positive for MSI-high are candidates for treatment with ...

CMS Establishes 2019 Monthly Fee Schedule Amount for Optune®

Novocure (NASDAQ: NVCR) today announced the U.S Centers for Medicare & Medicaid Services (CMS) has established a 2019 monthly fee schedule amount for Optune. Additional details on the fee schedule amount and pricing methodology are available on the CMS website. The announcement by CMS follows an announcement earlier this morning by the durable medical equipment (DME) Medicare Administrative...

New research gives some biological clues to why women may be more likely than men to develop #Alzheimer’s disease and how this most common form of dementia varies by sex. https://buff.ly/32zwOp9 

New research gives some biological clues to why women may be more likely than men to develop #Alzheimer’s disease and how this most common form of dementia varies by sex. https://buff.ly/32zwOp9 

Researchers at @UMontreal report that a mild gut infection can result in motor symptoms and brain pathology resembling #Parkinsons disease in mice that carry a gene mutation associated with the disorder in humans: http://ow.ly/ujM850v4XfR 

Researchers at @UMontreal report that a mild gut infection can result in motor symptoms and brain pathology resembling #Parkinsons disease in mice that carry a gene mutation associated with the disorder in humans: http://ow.ly/ujM850v4XfR 

IRS Notice, Newly Introduced Medicare Legislation Work to Expand Benefits of Health Savings Accounts for Millions of Americans

HealthEquity helps introduce legislation that would allow Medicare recipients to open and contribute to HSAs; IRS expands preventive care benefit options for chronic conditions HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account (HSA) non-bank custodian, participated in drafting legislation announced today that along with a new IRS notice, will expand the...

Can Fixing Sleep Apnea Affect Depression?

Continuous positive airway pressure treatment was associated with significantly improved depression in patients with established cardiovascular disease.

Takeda Brings Rare Disease Drugs To India But Access Questions Linger

Takeda has introduced rare disease therapies from Shire’s portfolio in India and appears to be shifting gears in a market...   

Regenerage International, IIMET, and Bioquark Inc. to Collaborate on Clinical Study in Biologic Age Reversal of Photodamaged Skin

Regenerage, IIMET, and Bioquark, Inc. are undertaking a 12-week clinical trial, of a novel topical formulation, to study biologic reversal of aging in photodamaged skin. CHICAGO, PHILADELPHIA, an ZAPOPAN, Mexico (PRWEB) July 18, 2019 Regenerage International Inc., a clinical company focused on therapeutic and consumer applications of regenerative healthcare; IIMET, a Mexico based contract researc...

ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2019 Operating Results

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, August 2, 2019 to discuss its second quarter operating results. Management will also provide a brief update on the business. CONFERENCE CALL INFORMATION To access the live call ...

Ironwood Pharmaceuticals to Host Second Quarter 2019 Investor Update Call

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2019 investor update conference call and webcast at 4:30 p.m. Eastern Time on Tuesday, July 30, 2019. Individuals interested in participating in the call should dial (866) 393-4306 (U.S. and Canada) or (734) 385-2616 (international) using conference ID number 1896718. To access the webcast, please visit ...

ProMIS Neurosciences Inc.: ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019

Alzheimer's Association International Conference includes oral session on PMN310 for Alzheimer's disease and poster presentation on ALSTORONTO and CAMBRIDGE, Mass., July 18, 2019. Additionally, Chi...

Scientists say they nearly eliminated disease-carrying mosquitoes on two islands in #China using a new technique. https://buff.ly/2NYnF63 

Scientists say they nearly eliminated disease-carrying mosquitoes on two islands in #China using a new technique. https://buff.ly/2NYnF63 

LifeMax Receives Rare Pediatric Disease Designation from the FDA for LM-030 for the Treatment of Netherton Syndrome

PALO ALTO, Calif.–(BUSINESS WIRE)–LifeMax Laboratories, Inc. (“LifeMax”), a private company focused on treating rare diseases with few or no therapeutic options, today announced that the Food & Drug Administration (FDA) granted rare pediatric disease designation to LM-030, an investigational therapy licensed from Novartis and ready to enter into pivotal clinical trials for the ...

New IRS rule opens up preventive care coverage for chronic disease by high-deductible health plans

Applicable products and services include insulin, ACE inhibitors, inhaled corticosteroids, retinopathy screenings, glucometers, statins and SSRIs.

Ping An Good Doctor Joins Forces With Nearly 50 Hospitals in China to Build New "Internet Hospitals" Model

SHANGHAI, July 18, 2019 /PRNewswire/ -- The world leading online healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", or the "Company"; stock code: 01833.HK), has announced that it had reached strategic cooperation with nearly 50 hospitals across China, including the Aviation General Hospital of China Medical University, ...

PER® Global Presents the 4th Annual European Congress on Immunotherapies in Cancer™ in Barcelona

Continuing medical education conference will focus on the latest emerging data on immunotherapies PER Global, a worldwide leading resource for continuing medical education, will host the 4th Annual European Congress on Immunotherapies in Cancer™. The congress will take place 15-16 Nov. 2019 at the Hilton Barcelona in Spain. This year’s program will be co-chaired by Antoni Ribas, M.D., Ph.D...

Society for Immunotherapy of Cancer Publishes First Clinical Immunotherapy Treatment Guidelines for Squamous Cell Carcinoma of the Head and Neck

The Society for Immunotherapy of Cancer (SITC) has published the first clinical immunotherapy treatment guidelines for squamous cell carcinoma of the head and neck (HNSCC), providing oncologists and other advanced practice providers a clinical roadmap to treating this disease with immunotherapies approved in the United States. “The Society for Immunotherapy of Cancer consensus statement on immun...

Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets

Kronos Bio has raised $105 million in financing to develop therapies intended to target disease-causing proteins that have so far eluded the best efforts of drug hunters. The Series A round of funding announced Thursday was led by Vida Ventures and Omega Funds. Drugs typically work by either binding to a target site on a […]

Preclinical Research Suggests Role for ITK Inhibition in Monocytic MDSCs in CLL

Monocytic myeloid-derived suppressor cells increased with ibrutinib treatment in a preclinical model of chronic lymphocytic leukemia, suggesting a role for ITK inhibition in this cell population.


Quick Search

News Quicklinks